A new trading day began on Monday, with Essa Pharma Inc (NASDAQ: EPIX) stock price up 3.23% from the previous day of trading, before settling in for the closing price of $1.86. EPIX’s price has ranged from $1.40 to $11.67 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 12.11%. With a float of $43.38 million, this company’s outstanding shares have now reached $44.39 million.
The extent of productivity of a business whose workforce counts for 35 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Essa Pharma Inc (EPIX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Essa Pharma Inc is 2.22%, while institutional ownership is 98.86%. The most recent insider transaction that took place on Nov 01 ’24, was worth 12,018,409. In this transaction 10% Owner of this company sold 7,879,583 shares at a rate of $1.53, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 07 ’24, when Company’s Chief Operating Officer sold 694 for $6.03, making the entire transaction worth $4,185. This insider now owns 7,776 shares in total.
Essa Pharma Inc (EPIX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 12.11% per share during the next fiscal year.
Essa Pharma Inc (NASDAQ: EPIX) Trading Performance Indicators
Here are Essa Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 38.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of Essa Pharma Inc (EPIX)
The latest stats from [Essa Pharma Inc, EPIX] show that its last 5-days average volume of 0.84 million was superior to 0.62 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 91.96%. Additionally, its Average True Range was 0.11.
During the past 100 days, Essa Pharma Inc’s (EPIX) raw stochastic average was set at 8.02%, which indicates a significant decrease from 94.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.96% in the past 14 days, which was lower than the 218.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.1720, while its 200-day Moving Average is $5.0734. Now, the first resistance to watch is $1.9625. This is followed by the second major resistance level at $2.0051. The third major resistance level sits at $2.0701. If the price goes on to break the first support level at $1.8549, it is likely to go to the next support level at $1.7899. Assuming the price breaks the second support level, the third support level stands at $1.7473.
Essa Pharma Inc (NASDAQ: EPIX) Key Stats
With a market capitalization of 86.62 million, the company has a total of 44,389K Shares Outstanding. Currently, annual sales are 0 K while annual income is -28,540 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,360 K.
